For the Inventor, By the Inventor

Enter assignee name

Schaffhausen, Switzerland

Occlutech Holding Ag

USPTO Granted Patents = 30

CIPO Patents = 4

EPO Patents = 33

Trademarks = 2

Forward Citations = 420

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Robert Moszner (7 out of 16 patents)

Rüdiger Ottma (7 out of 13 patents)

Michael Heipl (5 out of 6 patents)

4. Mehmet Hakan Akpinar (5 out of 6 patents)

5. Hans-Reiner Figulla (4 out of 34 patents)

6. Friedrich Moszner (4 out of 8 patents)

7. Herbert Maslanka (3 out of 5 patents)

8. Stevan Nielsen (3 out of 4 patents)

9. Michael Köppe (3 out of 3 patents)

10. Kathrin Schmidt (3 out of 3 patents)

11. Elaheh Malakan Rad (2 out of 3 patents)

12. Ziyad Mousa Hijazi (2 out of 3 patents)

13. Andreas Henseler (2 out of 5 patents)

14. Florian Krizanic (2 out of 4 patents)

15. Hans Reiner Figulla (2 out of 8 patents)

30 patents: Sort by Forward Citations

1. 12303117 - Asymmetric occluder device (2025-05-20),

2. 11571198 - Implant, medical implant, and method for delivery of a medical implant (2023-02-07),

3. 11512416 - Braided medical device and manufacturing method thereof (2022-11-29),

4. 11213282 - Implant, medical implant, and method for delivery of a medical implant (2022-01-04),

5. 11197660 - Asymmetric occluder device (2021-12-14),

6. 10905406 - Medical implantable occlusion device, and method for implantation thereof (2021-02-02),

7. 10808341 - Braided medical device and manufacturing method thereof (2020-10-20),

8. 10743852 - Occlusion device and method for its manufacture (2020-08-18),

9. 10595999 - Flow regulating device in the heart (2020-03-24),

10. 10156030 - Braided medical device and manufacturing method thereof (2018-12-18),

11. 10064612 - Asymmetric occluder device (2018-09-04),

12. 9993234 - Implant, medical implant, and method for delivery of a medical implant (2018-06-12),

13. 9901330 - Medical implantable occlusion device, and method for implantation thereof (2018-02-27),

14. RE46705 - Occlusion device for occluding an atrial auricula and method for producing same (2018-02-12),

15. 9839430 - Device for closing openings or cavities in blood vessels (2017-12-12),

Occlutech Holding AG is a global healthcare company specializing in the development and manufacturing of innovative medical devices for the treatment of structural heart disease. With a strong focus on research and engineering, Occlutech aims to improve patient outcomes by providing high-quality, minimally invasive solutions. The company's product portfolio includes occlusion devices, such as atrial septal defect and patent foramen ovale occluders, as well as stent systems for vascular interventions. Headquartered in Germany, Occlutech operates globally, serving healthcare professionals and patients in over 80 countries.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

30 Patents

#17 in Schaffhausen

#429 in Switzerland

#21,168 in the World

Schaffhausen, Switzerland

Occlutech Holding Ag

Forward Citations = 420

38 inventors:

Robert Moszner (7 out of 16 patents)

Rüdiger Ottma (7 out of 13 patents)

Michael Heipl (5 out of 6 patents)

4. Mehmet Hakan Akpinar (5 out of 6 patents)

5. Hans-Reiner Figulla (4 out of 34 patents)

Please report any incorrect information to support@idiyas.com

Loading…